Screening and Risk Prediction of High-risk Population for Diabetes of Exocrine Pancreas based on Serum Metabolomics Technology

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200064550

Enrollment

Unknown

Registered

2022-10-11

Start date

2022-10-01

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes of Exocrine Pancreas

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Preliminary diagnosis of acute pancreatitis (AP), meeting at least 2 of the following 3 criteria: (1) Serum amylase/pancreatic amylase and/or lipase levels are at least 3 times the upper limit of normal; (2) Acute abdominal pain suggestive of acute pancreatitis, with or without radiating back pain; (3) Acute pancreatitis manifestations supported by imaging evidence (ultrasound/CT/MRI); 2. Age 18-75 years old; 3. Admitted to hospital within 72 hours of abdominal pain symptoms.

Exclusion criteria

Exclusion criteria: 1. Recurrent or chronic pancreatitis; 2. Previous history of diabetes or hypoglycemic drug treatment; 3. Abnormal glycated hemoglobin (HbA1c) during hospitalization; 4. Other pancreatic injuries, including trauma, pancreatectomy, benign and malignant pancreatic tumors, cystic fibrosis, hemochromatosis, fibrocalcific pancreatic disease or rare genetic diseases; 5. Severe heart, liver, kidney insufficiency or malignant tumor; 6. History of immune system diseases or hormone medication; 7. Pregnancy and lactation; 8. Unable to cooperate with follow-up due to mental illness or other reasons.

Design outcomes

Primary

Measure	Time frame
incidence rate;risk factors;	—

Countries

China

Contacts

Public ContactLing Li

Zhongda Hospital Affiliated to Southeast University

dr_liling@126.com+86 13951606816

Outcome results